Drug Profile


Alternative Names: E 0167; EA 0167; Glakay; KayTwo; Kaytwo® Syrup 0.2%; Menaquinone-4; MK 4; MQ 4; Vitamin K2

Latest Information Update: 04 Nov 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Eisai Co Ltd
  • Class Calcium regulators; Naphthoquinones; Osteoporosis therapies; Vitamins
  • Mechanism of Action Osteogenesis stimulants; Prostaglandin receptor antagonists; Vitamin modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Postmenopausal osteoporosis; Vitamin deficiency
  • Discontinued Liver cancer

Most Recent Events

  • 24 Jun 2018 Biomarkers information updated
  • 25 May 2012 Registered for the prevention of Vitamin K deficiency haemorrrhage (0.2% syrup) in neonates and infants in Japan (PO)
  • 22 Oct 2004 Phase-II clinical trials in liver cancer in Japan (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top